Management Team
Melior’s management has combined experience of over 150 years of drug discovery and development know-how. Our management and staff have spent years, prior to Melior, working in the most recognized multinational pharmaceutical companies. All of our management team has participated in therapeutic programs that have progressed to advanced clinical stage.
Andrew Reaume, PhD, MBA
President and CEO,
Co-Founder
Patty Ferrante
Chief Operating Officer
Weina Cong, PhD
Director of Cardiovascular & Metabolic Disease
Gennady N. Smagin, MD, PhD
Director of Pharmacology
John A. Gruner, PhD
Director of Neurophysiology
Amy DiCamillo
Director of Scientific Operations
Xiaodong Li, MD, PhD
Director of Lab Immunology and Inflammation
Alexandra Liddane, PhD
Senior Scientist
Erin Davis
Director of Lab Operations